Skip to content
Screener

Net Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.74B+7.4%
Danaher logo
DanaherDHR
$870M+56.8%
Bruker logo
BrukerBRKR
-$52M-784%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
-$13.47M+60.8%
Revvity logo
RevvityRVTY
$40.72M-3.6%
Agilent Technologies logo
Agilent TechnologiesA
$339M+57.7%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemQuarter Ended / March 31, 2026Quarter Ended / March 31, 2025Nine Months Ended / March 31, 2026Nine Months Ended / March 31, 2025
Other income (expense)(4,270)(434)(7,614)(4,793)
Earnings before income taxes71,22538,274170,000121,322
Income taxes20,17815,68642,75930,244
Net earnings$51,047$22,588$127,241$91,078
Other comprehensive income (loss):
Foreign currency translation income (loss)(4,352)5,311(4,440)1,049
Unrealized gains (losses) on derivative instruments(160)(1,713)(2,536)(4,785)
Other comprehensive income (loss)(4,512)3,598(6,976)(3,736)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's net income?
Bio-Techne (TECH) reported net income of $51.05M in Q1 2026.
How has Bio-Techne's net income changed year-over-year?
Bio-Techne's net income increased by 126.0% year-over-year, from $22.59M to $51.05M.
What is the long-term trend for Bio-Techne's net income?
Over 2 years (2022 to 2024), Bio-Techne's net income has grown at a -21.4% compound annual growth rate (CAGR), from $272.05M to $168.11M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Bio-Techne's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude